Overview of molecular diagnosis and targeted treatment of tumor

Abstract

Zheng Xiaowen， Wang Yuping， Zhou Yongning. Overview of molecular diagnosis and targeted treatment of tumor[J]. Journal of International Oncology, 2015, 42(10): 756-758.

［1］陈运贤. 恶性肿瘤的分子诊断技术［J］. 分子诊断与治疗杂志, 2009, 1(2): 73-76. ［2］李梦菲, 唐秋莎, 陈道桢. 肿瘤靶向治疗的研究进展［J］. 中国医药导报, 2014, 11(25)： 165-168. ［3］邹丹丹, 窦骏. 恶性肿瘤的分子靶点检测和靶向治疗［J］. 临床与实验病理学杂志, 2012, 28(9): 1026-1029. ［4］陈希, 包黎明. 基因组技术在肿瘤分子诊断中的应用［J］. 重庆医科大学学报, 2011, 36(7): 769-771. ［5］ Rushlow DE, Mol BM, Kennett JY, et al. Characterisation of retinoblastomas without rb1 mutations: genomic, gene expression, and clinical studies［J］. Lancet Oncol, 2013, 14(4): 327-334. ［6］齐晓伟, 姜军. Wilms 瘤基因 1 与实体肿瘤发生、演进关系的研究进展［J］. 中华外科杂志, 2013, 51(5): 461-463. ［7］武治国, 陈明清, 董坚, 等. 家族性腺瘤性息肉病——家系调查及 apc 基因胚系突变分析［J］. 国际遗传学杂志, 2010, （2): 117-121. ［8］张淑英, 余志金, 甘爱华, 等. 遗传性非息肉病性结直肠癌遗传易感基因的研究现状［J］. 胃肠病学和肝病学杂志, 2012, 21(11): 989-993. ［9］罗娟娟. Brca1与乳腺癌［J］. 河南医学研究, 2011, 20(3): 382-384. ［10］欧志英, 夏慧敏. MicroRNA在肿瘤分子诊断中的应用［J］. 分子诊断与治疗杂志, 2013, (1): 1-7. ［11］ Cervera P, Fléjou JF. Changing pathology with changing drugs: tumors of the gastrointestinal tract［J］. Pathobiology, 2011, 78(2): 76-89. ［12］樊向荣. 早期胃癌分子诊断及靶向治疗进展［J］. 临床合理用药杂志, 2013, 6(15): 7-8. ［13］薛剑, 娄加陶. 肺癌分子诊断学研究进展［J］. 上海交通大学学报：医学版, 2011, 31（3）: 373-377. ［14］ Tietze R, Lyer S, Durr S, et al. Nanoparticles for cancer therapy using magnetic forces［J］. Nanomedicine(Lond), 2012, 7(3): 447-457. ［15］陈明义, 田京. 超顺磁性氧化铁纳米颗粒在肿瘤靶向治疗中的应用进展［J］. 天津医药, 2013, 41(6): 618-620. ［16］ Maeng JH, Lee DH, Jung KH, et al. Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer［J］. Biomaterials, 2010, 31(18): 4995-5006.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing.Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients[J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang.Role of PFDN and its subunits in tumorigenesis and tumor development[J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying.Research progress of habitat analysis in radiomics of malignant tumors[J]. Journal of International Oncology, 2024, 51(5): 292-297.

Overview of molecular diagnosis and targeted treatment of tumor

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments